Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Xing, Yingying"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł :
Corrigendum to "MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42" [Biochem. Biophys. Res. Commun. 472 (1) (2016) 262-9].
Autorzy :
Chou J; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
Wang B; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
Zheng T; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
Li X; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.
Zheng L; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
Hu J; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
Zhang Y; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
Xing Y; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
Xi T; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2020 Jan 08; Vol. 521 (2), pp. 541-543. Date of Electronic Publication: 2019 Nov 08.
Typ publikacji :
Published Erratum
Tytuł :
StarD13 3'-untranslated region functions as a ceRNA for TP53INP1 in prohibiting migration and invasion of breast cancer cells by regulating miR-125b activity.
Autorzy :
Zheng L; School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China.
Li X; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Chou J; School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China.
Xiang C; School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China.
Guo Q; School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China.
Zhang Z; School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China.
Guo X; School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China.
Gao L; School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China.
Xing Y; School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China.
Xi T; School of Life Science and Technology, Jiangsu Key Laboratory of Carcinogenesis and Intervention, Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China. Electronic address: .
Pokaż więcej
Źródło :
European journal of cell biology [Eur J Cell Biol] 2018 Jan; Vol. 97 (1), pp. 23-31. Date of Electronic Publication: 2017 Nov 11.
Typ publikacji :
Journal Article
MeSH Terms :
3' Untranslated Regions*
Gene Expression Regulation, Neoplastic*
Neoplasm Invasiveness*
Breast Neoplasms/*pathology
Carrier Proteins/*metabolism
Heat-Shock Proteins/*metabolism
MicroRNAs/*genetics
Tumor Suppressor Proteins/*metabolism
Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Carrier Proteins/genetics ; Cell Proliferation ; Female ; GTPase-Activating Proteins ; Heat-Shock Proteins/genetics ; Humans ; Tumor Cells, Cultured ; Tumor Suppressor Proteins/genetics ; Wound Healing
Czasopismo naukowe
Tytuł :
MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42.
Autorzy :
Chou J; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
Wang B; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
Zheng T; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
Li X; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jingsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, People's Republic of China.
Zheng L; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
Hu J; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
Zhang Y; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
Xing Y; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China.
Xi T; School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing 210009, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2016 Mar 25; Vol. 472 (1), pp. 262-9. Date of Electronic Publication: 2016 Feb 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
MicroRNAs/*genetics
MicroRNAs/*metabolism
RNA, Long Noncoding/*genetics
cdc42 GTP-Binding Protein/*genetics
3' Untranslated Regions ; Binding, Competitive ; Breast Neoplasms/physiopathology ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Movement/physiology ; Down-Regulation ; Epithelial-Mesenchymal Transition/genetics ; Female ; Humans ; MCF-7 Cells ; Neoplasm Invasiveness/genetics ; Neoplasm Invasiveness/pathology ; Neoplasm Invasiveness/physiopathology ; RNA, Long Noncoding/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA, Neoplasm/genetics ; RNA, Neoplasm/metabolism ; Up-Regulation
Czasopismo naukowe
Tytuł :
Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Autorzy :
Xing Y; Biotechnology Center, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Liu W; Biotechnology Center, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Li X; Biotechnology Center, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Guo L; School of Laboratory Medicine, Ningxia Medical University, Yinchuan, China.
Lv X; Biotechnology Center, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Xi T; Biotechnology Center, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China. Electronic address: .
Pokaż więcej
Źródło :
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2015 Jul 03; Vol. 462 (3), pp. 269-74. Date of Electronic Publication: 2015 May 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adjuvants, Immunologic/*administration & dosage
Bacterial Vaccines/*administration & dosage
Bacterial Vaccines/*immunology
Chitosan/*administration & dosage
Chitosan/*immunology
Cholera Toxin/*administration & dosage
Cholera Toxin/*immunology
CpG Islands/*immunology
Helicobacter Infections/*prevention & control
Helicobacter pylori/*immunology
Urease/*administration & dosage
Urease/*immunology
Administration, Oral ; Animals ; Antibodies, Bacterial/biosynthesis ; Antibodies, Bacterial/blood ; Antibody Specificity ; Bacterial Vaccines/genetics ; Cytokines/biosynthesis ; Epitopes/administration & dosage ; Helicobacter Infections/immunology ; Helicobacter Infections/microbiology ; Helicobacter pylori/enzymology ; Helicobacter pylori/genetics ; Immunity, Mucosal ; Immunoglobulin A, Secretory/biosynthesis ; Male ; Mice ; Mice, Inbred BALB C ; Urease/genetics ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/genetics ; Vaccines, Synthetic/immunology
Czasopismo naukowe
Tytuł :
MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells.
Autorzy :
Yin R; Pharmaceutical Research Center, School of Chemistry & Chemical Engineering, Southeast University, Nanjing 211189, China.
Bao W
Xing Y
Xi T
Gou S
Pokaż więcej
Źródło :
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2012 Jan 13; Vol. 417 (2), pp. 771-6. Date of Electronic Publication: 2011 Dec 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Cycle/*physiology
Endothelial Cells/*physiology
MicroRNAs/*physiology
Neovascularization, Physiologic/*physiology
Cell Cycle/genetics ; Cell Proliferation ; Human Umbilical Vein Endothelial Cells/cytology ; Human Umbilical Vein Endothelial Cells/physiology ; Humans ; MicroRNAs/genetics ; Neovascularization, Pathologic/genetics ; Neovascularization, Physiologic/genetics ; Receptor, Fibroblast Growth Factor, Type 2/genetics
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies